Published in J Biol Chem on December 03, 1999
Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon. Blood (2007) 0.92
Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis. J Biol Chem (2008) 0.83
The crystal structure of thrombin-activable fibrinolysis inhibitor (TAFI) provides the structural basis for its intrinsic activity and the short half-life of TAFIa. J Biol Chem (2008) 0.81
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites. J Biol Chem (2011) 0.81
The roles of selected arginine and lysine residues of TAFI (Pro-CPU) in its activation to TAFIa by the thrombin-thrombomodulin complex. J Biol Chem (2008) 0.79
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI). BMC Biochem (2009) 0.76
A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture. J Biol Chem (2009) 0.76
Flexibility of the thrombin-activatable fibrinolysis inhibitor pro-domain enables productive binding of protein substrates. J Biol Chem (2010) 0.75
A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman. Lab Med (2016) 0.75
Activated thrombin-activatable fibrinolysis inhibitor is generated in vivo at levels that can substantially affect fibrinolysis in chimpanzees in response to thrombin generation. J Thromb Haemost (2008) 0.75
Comparison of DNA sequences with protein sequences. Genomics (1997) 7.76
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A (1997) 3.78
Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet (1977) 3.43
Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci U S A (2000) 3.13
Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci Lett (2000) 2.22
Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. Biochemistry (1986) 2.20
Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev (1994) 2.00
An evaluation of the API ZYM system as a means of classifying spirochaetes associated with swine dysentery. Vet Rec (1979) 1.80
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet (2009) 1.64
Effect of cysteine-25 on the ionization of histidine-159 in papain as determined by proton nuclear magnetic resonance spectroscopy. Evidence for a his-159--Cys-25 ion pair and its possible role in catalysis. Biochemistry (1981) 1.64
Imidazole-catalyzed displacement of an amine from an amide by a neighboring hydroxyl group. A model for the acylation of chymotrypsin. J Am Chem Soc (1971) 1.59
Molecular model of the specificity pocket of the hepatitis C virus protease: implications for substrate recognition. Proc Natl Acad Sci U S A (1994) 1.57
Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem (1994) 1.51
Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies. Arch Biochem Biophys (1985) 1.48
Predominance of tyrosine phosphorylation of insulin receptors during the initial response of intact cells to insulin. J Biol Chem (1985) 1.45
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43
Spectrophotometric ass for D-ribose-5-phosphateketol-isomerase and for D-ribulose-5-phosphate 3-epimerase. Anal Biochem (1970) 1.42
Randomised study of n of 1 trials versus standard practice. BMJ (1996) 1.41
Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod (1994) 1.40
Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. Br J Anaesth (1984) 1.30
Phosphorus cycling in a northern hardwood forest: biological and chemical control. Science (1984) 1.25
Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis. Nature (1985) 1.25
Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. J Biol Chem (1985) 1.23
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin. J Biol Chem (1983) 1.20
Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res (1996) 1.19
The detection and identification of intermediates of the pentose phosphate cycle and related compounds. J Chromatogr (1968) 1.19
Physiological functions of the pentose phosphate pathway. Cell Biochem Funct (1986) 1.18
Mucormycosis. Laryngoscope (1977) 1.18
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA. Mol Genet Metab (2013) 1.17
The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. J Biol Chem (1990) 1.15
Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate. Biochemistry (1994) 1.11
The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill (2011) 1.09
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position. J Med Chem (1998) 1.08
Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: interactive binding between substrates and a preferred kinetic pathway. Biochemistry (1993) 1.08
Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-A alpha 16 by a histidyl residue. Evidence for thrombin-catalyzed hydrolysis at a histidyl residue. J Biol Chem (1981) 1.08
Factors influencing the incidence of gonorrhoea and non-gonococcal urethritis in men in an industrial city. Br J Vener Dis (1970) 1.08
Potentiometric determination of ionizations at the active site of papain. Biochemistry (1976) 1.07
Dissociation and association of the HIV-1 protease dimer subunits: equilibria and rates. Biochemistry (1994) 1.07
Reaping maximum benefits from minimally invasive surgery. J Healthc Mater Manage (1994) 1.07
Solution oligomerization of the rev protein of HIV-1: implications for function. Biochemistry (1993) 1.06
The costs of spinal cord injury. Paraplegia (1978) 1.06
Kinetic pathway for the slow to fast transition of thrombin. Evidence of linked ligand binding at structurally distinct domains. J Biol Chem (1997) 1.06
Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial. Diabetologia (2010) 1.05
Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer (2002) 1.05
Latent proteinase activity of gamma-glutamyl transpeptidase light subunit. J Biol Chem (1979) 1.04
Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter. J Neurochem (2000) 1.03
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey. Circulation (1995) 1.03
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia (2008) 1.03
Structural characterization of the rat carboxypeptidase A1 and B genes. Comparative analysis of the rat carboxypeptidase gene family. J Biol Chem (1988) 1.03
Comparison of injuries in elite senior and junior Australian football. J Sci Med Sport (1998) 1.02
Kinetic parameters for the binding of p-nitrophenyl alpha-d-mannopyranoside to concanavalin A. Arch Biochem Biophys (1976) 1.02
A complementary DNA sequence that predicts a human pancreatic amylase primary structure consistent with the electrophoretic mobility of the common isozyme, Amy2 A. Mol Biol Med (1984) 1.01
Vegetative and structural characteristics of agricultural drainages in the Mississippi Delta landscapes. Environ Pollut (2004) 1.00
Dependence of the catalytic activity of papain on the ionization of two acidic groups. J Biol Chem (1978) 0.99
Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry (1985) 0.99
Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes. Biochemistry (1988) 0.98
The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J Biol Chem (2001) 0.98
Purification and properties of D-ribulose-5-phosphate 3-epimerase from calf liver. Biochim Biophys Acta (1979) 0.98
Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis. Thromb Haemost (1998) 0.96
Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem (1994) 0.96
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J (2014) 0.94
Performance demands of professional male tennis players. Br J Sports Med (2006) 0.94
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis. J Thromb Haemost (2008) 0.94
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. J Biol Chem (1993) 0.94
Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry (1983) 0.94
Comparison of effects of antihypertensive agents on normotensive ratsand rats with "metacorticoid" and adrenal regeneration hypertension. Cardiovasc Res Cent Bull (1967) 0.94
Purification of active herpes simplex virus-1 protease expressed in Escherichia coli. J Biol Chem (1994) 0.94
Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin. J Biol Chem (1990) 0.93
A two-step procedure for purification of papain from extract of papaya latex. Arch Biochem Biophys (1974) 0.93
Agricultural drainage ditches mitigate phosphorus loads as a function of hydrological variability. J Environ Qual (2008) 0.92
Phosphorylation of highly purified growth hormone receptors by a growth hormone receptor-associated tyrosine kinase. J Biol Chem (1989) 0.92
Ionization of a nitrophenol-containing reporter group at the active site of papain. Biochemistry (1974) 0.92
Partial purification and kinetic properties of ribose-5-phosphate ketol-isomerase and ribulose-5-phosphate 3-epimerase from various sources. Biochim Biophys Acta (1973) 0.92
A reagent for covalently attaching biotin to proteins via a cleavable connector arm. Arch Biochem Biophys (1982) 0.92
Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Biochemistry (1992) 0.92
Reactions of pyrzdoxal 5'-phosphate, 6-aminocaproic acid, cysteine, and penicilamine. Models for reactions of Schiff base linkages in pyridoxal 5'-phosphate-requiring enymes. J Biol Chem (1975) 0.91
Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogs. J Biol Chem (1998) 0.91
A facile system for construction of HSV-1 variants: site directed mutation of the UL26 protease gene in HSV-1. J Virol Methods (1996) 0.91
A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2010) 0.91
The inhibition of pyruvate kinase by ATP. Biochem Biophys Res Commun (1968) 0.90
Serum immunoreactive trypsin concentration after a Lundh meal. Its value in the diagnosis of pancreatic disease. J Clin Pathol (1979) 0.90
Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII. Biochemistry (1987) 0.90
D-serine dehydratase from Escherichia coli. DNA sequence and identification of catalytically inactive glycine to aspartic acid variants. J Biol Chem (1988) 0.90
Comparison of amphibian and human ClC-5: similarity of functional properties and inhibition by external pH. J Membr Biol (1999) 0.90
Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A. Thromb Res (1993) 0.90
Determination of a low pK for histidine-159 in the S-methylthio derivative of papain by proton nuclear magnetic resonance spectroscopy. Biochemistry (1981) 0.90
The glycine-rich region of Escherichia coli D-serine dehydratase. Altered interactions with pyridoxal 5'-phosphate produced by substitution of aspartic acid for glycine. J Biol Chem (1988) 0.90
Hydrological variability and agricultural drainage ditch inorganic nitrogen reduction capacity. J Environ Qual (2007) 0.90
Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution. Arch Biochem Biophys (1995) 0.89
Nutrient mitigation capacity in Mississippi Delta, USA drainage ditches. Environ Pollut (2009) 0.89
Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem Res (2001) 0.89
Carbohydrate binding properties of the stinging nettle (Urtica dioica) rhizome lectin. Arch Biochem Biophys (1986) 0.89